Ownership history in Ghost Tree Capital, LLC · 6 quarters on record
This page tracks every 13F SEC filing in which Ghost Tree Capital, LLC reported a position in PHATHOM PHARMACEUTICALS INC (PHAT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2024 Q3 | REDUCED | 375,000 | -225,000 | -37.5% | 2.05% | $6.8M | $18.08 |
| 2024 Q2 | ADDED | 600,000 | +115,000 | +23.7% | 1.94% | $6.2M | $10.30 |
| 2024 Q1 | ADDED | 485,000 | +99,759 | +25.9% | 1.43% | $5.2M | $10.62 |
| 2023 Q4 | REDUCED | 385,241 | -9,759 | -2.5% | 1.15% | $3.5M | $9.13 |
| 2023 Q3 | ADDED | 395,000 | +240,750 | +156.1% | 1.35% | $4.1M | $10.37 |
| 2023 Q2 | INITIATED | 154,250 | — | — | 0.73% | $2.2M | $14.32 |
As of 2025 Q4 — sorted by position size